Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023.

Clin Mol Hepatol · 2025 · PMC12016658 · PMID 39610192

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

did not reach statistical significanceP =0.067so close (0.05 < p ≤ 0.1)

4A – 4F ), the proportion of significant fibrosis and advanced fibrosis among individuals with MASLD was higher during the COVID-19 era compared to the pre-COVID-19 era; however, these differences did not reach statistical significance ( P =0.067 and 0.081 for advanced fibrosis; P =0.083 and 0.125 for significant fibrosis).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.